Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Revenue from Customers by Products) (Details)

v3.20.4
Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) - USD ($)
 3 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenue, Major Customer [Line Items]    
Revenues $ 14,616,989 $ 10,578,016
FC2 Segment [Member]    
Revenue, Major Customer [Line Items]    
Revenues 13,754,158 10,424,924
PREBOOST Segment [Member]    
Revenue, Major Customer [Line Items]    
Revenues 862,831 153,092
U.S. Prescription Channel Segment [Member] | FC2 Segment [Member]    
Revenue, Major Customer [Line Items]    
Revenues 9,101,739 6,051,130
Global Health Public Sector [Member] | FC2 Segment [Member]    
Revenue, Major Customer [Line Items]    
Revenues $ 4,652,419 $ 4,373,794